Programme

Two days of cutting-edge cancer research: keynote talks, selected presentations, poster sessions and networking.

Register Meet the speakers

The detailed schedule is updated as speakers and selected presentations are confirmed.

Thursday, October 1, 2026

Session 1 — Organ-specific malignancy: From basic research to therapeutic innovation

09:15 – 10:00
Keynote

Florence Dalenc

IUCT-Oncopole (Toulouse, France)

10:00 – 10:20

Oceane Dainese Marque

Sphingosine 1-phosphate triggers a keratinocyte-driven pro-inflammatory microenvironment that fuels phenotype switching in melanoma
10:20 – 10:40
Tech talk

InvivoGen

10:40 – 11:00

Coffee break

Industry sponsors stands

11:00 – 11:20

Imene Gasmi

Tuft cells remodel the mucosal immune microenvironment to promote intestinal tumourigenesis
11:20 – 11:40

Ludmila Recoules

ZBTB16 reduces CAF activation and limits stromal-mediated chemoresistance in pancreatic cancer

Session 2 — Science Communication

11:40 – 12:30
Interactive workshop

Dafna Gold Melchior

Who's in the Room? The Art & Science of Audience-Centered Communication

12:30 – 12:40
Tech talk

MedChemExpress

12:40 – 14:10

Lunch

Industry sponsors stands

In parallel: Round table discussion · Meet the editor

Session 3 — Beyond the Known: Innovation and Advocacy in Pediatric Oncology

14:10 – 14:55
Keynote

Sebastiaan van Heesch

Princess Maxima Center for Pediatric Oncology (Utrecht, The Netherlands)

14:55 – 15:15

Bartolomeo Bosco

MYCN ecDNA shapes immune landscape and immunotherapy resistance in high-risk neuroblastoma
15:15 – 15:35

Klara Ueberschar

Evolution of therapy resistance in neuroblastoma using patient-derived organoid models
15:35 – 15:45
Extended lightning talk

Jigna Kundnani

Exploring metabolic rewiring and cellular heterogeneity upon mutant IDH inhibition in low-grade glioma
15:45 – 15:55
Extended lightning talk

Lena Westerhoff

Neuroblastoma shows many alternative splicing events that point to oncogenic mechanisms and vulnerabilities
15:55 – 16:15

Coffee break

Industry sponsors stands

16:15 – 17:00
Patient advocate

Leona Knox

Patient advocate · Head of Research at Solving Kids' Cancer UK

17:00 – 17:20

Lightning talks

1 minute / talk, selected on abstracts

17:20 – 18:45

Poster Session 1

Friday, October 2, 2026

Session 4 — Dynamic States in Cancer: Plasticity and Heterogeneity

09:00 – 09:45
Keynote

Matteo Iannacone

San Raffaele Scientific Institute (Milan, Italy)

09:45 – 10:05

Julia Majewska

Senescent macrophages drive immunosuppression: implications for cancer immunotherapy
10:05 – 10:15
Tech talk

Mantalys

10:15 – 10:25
Tech talk

Gen2i

10:25 – 10:45

Coffee break

Industry sponsors stands

10:45 – 11:30
Keynote

Marta Kovatcheva

IFOM — FIRC Institute of Molecular Oncology (Milan, Italy)

11:30 – 11:50

Lou Galliot

A germline PERK gain-of-function mutation rewires proteostasis, innate immunity and metabolism to recapitulate cancer stress adaptation
11:50 – 12:10

Jordi Badia-Ramentol

Functional diversity of cancer-associated fibroblasts shapes clinical outcomes in colorectal cancer
12:10 – 12:30

Lightning talks

1 minute / talk, selected on abstracts

12:30 – 14:25

Lunch

Industry sponsors stands

In parallel: Meet the editor · Poster Session 2 (13:00 – 14:25)

Session 5 — Transforming Precision Oncology Through Computational Approaches

14:25 – 15:10
Keynote

Altuna Akalin

Berlin Institute for Medical Systems Biology, Max Delbrück Center (Berlin, Germany)

How AI is reshaping life sciences research: from omics to healthcare
15:10 – 15:30

Mariano Molina

Integrative multiomic analysis identifies the tumor-adjacent liver microenvironment as a robust predictor of hepatocellular carcinoma recurrence
15:30 – 15:50

Sameer Panda

Tumor Immune MicroEnvironment (TIME) dictating lung cancer therapy resistance
15:50 – 16:10

Coffee break

Industry sponsors stands

Session 6 — The Editor's Perspective

16:10 – 16:50
Keynote

Daniela Marin

Senior Editor, The Lancet Haematology

“So you want to get published”

Join us in Toulouse

Two days to learn, present, network and shape the future of cancer research.

Register Who attends?